Table 3.
Kidney pathology findings in COVID-19 and AKI
| Patient No. | Main Pathology Finding | Glomeruli (Total/Globally Sclerosed) | IFTA, % | AAS | Electron Microscopy |
|---|---|---|---|---|---|
| 1 | ATN and FSGS/healed collapse | 29/4 | 30 | Severe | Moderate segmental effacement of podocyte foot processes |
| 2 | ATN with myoglobin cast nephropathy | 2/1 | 20 | Moderate | No significant findings |
| 3 | ATN | 3/1 | 15 | Severe | No significant findings |
| 4 | ATN | 8/3 | 15 | Mild | No significant findings |
| 5 | ATN and early nodular GS | 31/9 | 20 | Moderate | Mesangial expansion, thick GBMs |
| 6 | ATN and TMA | 1/0 | Mild | Moderate | Fibrin thrombi, subendothelial widening, endothelial injury |
| 7 | Cortical necrosis and TMA | 22/0 | 10 | Severe | Fibrin thrombi, subendothelial widening, endothelial injury |
| 8 | Crescentic GN and ATN | 9/0 | 10 | Mild | Subendothelial widening, endothelial injury |
| 9 | ATN on advanced chronic changes | 17/12 | 50 | Severe | Thin GBMs (221 nm) |
| 10 | ATN on advanced chronic changes | 14/10 | 50 | Moderate | Subendothelial widening, endothelial injury |
IFTA, interstitial fibrosis and tubular atrophy; AAS, arterial and arteriolar sclerosis; GS, glomerulosclerosis; GBM, glomerular basement membrane.